^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Thyroid Gland Medullary Carcinoma |
| Drug: | Prolia (denosumab) (RANK ligand inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Medullary Thyroid Cancer: Symptomatic disease or progression…Consider intravenous bisphosphonate or denosumab therapy fir bone metastases
